|
1
|
Tracy MS, Rosenberg SM, Dominici L and
Partridge AH: Contralateral prophylactic mastectomy in women with
breast cancer: Trends, predictors, and areas for future research.
Breast Cancer Res Treat. 140:447–452. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stucky CC, Gray RJ, Wasif N, Dueck AC and
Pockaj BA: Increase in contralateral prophylactic mastectomy:
Echoes of a bygone era? Surgical trends for unilateral breast
cancer. Ann Surg Oncol. 17(Suppl 3): S330–S337. 2010. View Article : Google Scholar
|
|
3
|
Kummerow KL, Du L, Penson DF, Shyr Y and
Hooks MA: Nationwide trends in mastectomy for early-stage breast
cancer. JAMA Surg. 150:9–16. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Adkisson CD, Bagaria SP, Parker AS, Bray
JM, Gibson T, Thomas CS, Heckman MG and McLaughlin SA: Which
eligible breast conservation patients choose mastectomy in the
setting of newly diagnosed breast cancer? Ann Surg Oncol.
19:1129–1136. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Portschy PR and Tuttle TM: Rise of
mastectomy. J Surg Oncol. 107:563–564. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Soran A, Kamali Polat A, Johnson R and
McGuire KP: Increasing trend of contralateral prophylactic
mastectomy: What are the factors behind this phenomenon? Surgeon.
12:316–322. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Janssen S, Holz-Sapra E, Rades D, Moser A
and Studer G: Nipple-sparing mastectomy in breast cancer patients:
The role of adjuvant radiotherapy (Review). Oncol Lett.
9:2435–2441. 2015.PubMed/NCBI
|
|
8
|
Fancellu A, Soro D, Castiglia P, Marras V,
Melis M, Cottu P, Cherchi A, Spanu A, Mulas S, Pusceddu C, et al:
Usefulness of magnetic resonance in patients with invasive cancer
eligible for breast conservation: A comparative study. Clin Breast
Cancer. 14:114–121. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fancellu A, Turner RM, Dixon JM, Pinna A,
Cottu P and Houssami N: Meta-analysis of the effect of preoperative
breast MRI on the surgical management of ductal carcinoma in
situ. Br J Surg. 102:883–893. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Agarwal S, Agarwal S, Neumayer L and
Agarwal JP: Therapeutic nipple-sparing mastectomy: Trends based on
a national cancer database. Am J Surg. 208:93–98. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
King TA, Sakr R, Patil S, Gurevich I,
Stempel M, Sampson M and Morrow M: Clinical management factors
contribute to the decision for contralateral prophylactic
mastectomy. J Clin Oncol. 29:2158–2164. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
King TA, Gurevich I, Sakr R, Patil S,
Stempel M and Morrow M: Occult malignancy in patients undergoing
contralateral prophylactic mastectomy. Ann Surg. 254:2–7. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Verhoog LC, Brekelmans CT, Seynaeve C, van
den Bosch LM, Dahmen G, van Geel AN, Tilanus-Linthorst MM, Bartels
CC, Wagner A, van den Ouweland A, et al: Survival and tumour
characteristics of breast cancer patients with germline mutations
of BRCA1. Lancet. 351:316–321. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rosenberg SM, Sepucha K, Ruddy KJ, Tamimi
RM, Gelber S, Meyer ME, Schapira L, Come SE, Borges VF, Golshan M,
et al: Local therapy decision-making and contralateral prophylactic
mastectomy in young women with early-stage breast cancer. Ann Surg
Oncol. 22:3809–3815. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chung A, Huynh K, Lawrence C, Sim MS and
Giuliano A: Comparison of patient characteristics and outcomes of
contralateral prophylactic mastectomy and unilateral total
mastectomy in breast cancer patients. Ann Surg Oncol. 19:2600–2606.
2012. View Article : Google Scholar : PubMed/NCBI
|
